USCB FINANCIAL HOLDINGS, INC.·4

Jan 28, 3:38 PM ET

DE LA AGUILERA LUIS 4

4 · USCB FINANCIAL HOLDINGS, INC. · Filed Jan 28, 2026

Research Summary

AI-generated summary of this filing

Updated

USCB CEO Luis De La Aguilera Receives 27,632-Share Award

What Happened
Luis De La Aguilera, President, CEO and a director of USCB Financial Holdings, received a grant of 27,632 restricted shares on January 27, 2026. The shares were granted at $0.00 (no cash exchanged), with a total reported acquisition value of $0. This is an equity award (transaction code A), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-01-27; filing date: 2026-01-28 (filed timely).
  • Grant: 27,632 restricted common shares; price reported $0.00; total $0.
  • Vesting (F1): these 27,632 shares vest one-third per year beginning January 27, 2027.
  • Prior restricted stock included (F2): filing references 70,685 shares from earlier grants (17,082 from a 25,653-share grant vesting from Jan 21, 2026; 4,045 from a 12,136-share grant vesting from Jan 22, 2025; 7,892 from a 23,678-share grant vesting from Mar 8, 2024; and 41,666 from a 125,000-share grant vesting from Dec 31, 2024).
  • Option vesting notes (F3–F5): prior stock options vesting schedules cited (25%/yr from Apr 1, 2017; 1/3/yr from Sep 23, 2020; 1/3/yr from Sep 27, 2022).
  • Shares owned after transaction: not specified in the provided filing excerpt.

Context
Restricted stock awards are subject to vesting and typically cannot be sold until they vest; here the new grant vests in three equal annual installments starting one year from grant. The $0.00 price indicates a compensation award rather than a market purchase. Such grants increase insider ownership over time as portions vest but do not represent an immediate sale or cash proceeds.

Insider Transaction Report

Form 4
Period: 2026-01-27
DE LA AGUILERA LUIS
DirectorPresident and CEO
Transactions
  • Award

    Class A Voting Common Stock

    [F1][F2]
    2026-01-27+27,632245,893 total
Holdings
  • Stock Option (Right to Buy)

    [F4]
    Exercise: $11.35From: 2020-09-23Exp: 2029-09-23Common Stock (40,000 underlying)
    40,000
  • Stock Option (Right to Buy)

    [F5]
    Exercise: $12.05From: 2022-09-27Exp: 2031-09-27Common Stock (160,000 underlying)
    160,000
  • Stock Option (Right to Buy)

    [F3]
    Exercise: $7.50From: 2017-04-01Exp: 2026-04-01Common Stock (10,000 underlying)
    10,000
Footnotes (5)
  • [F1]Represents the grant of 27,632 shares of restricted stock which vest at a rate of one-third per year commencing on January 27, 2027.
  • [F2]Includes 17,082 shares of restricted stock from a grant of 25,653 shares which commenced vesting at a rate of one-third per year on January 21, 2026, 4,045 shares of restricted stock from a grant of 12,136 shares which commenced vesting at a rate of one-third per year on January 22, 2025, 7,892 shares of restricted stock from a grant of 23,678 shares which commenced vesting at a rate of one-third per year on March 8, 2024, and 41,666 shares of restricted stock from a grant of 125,000 shares which commenced vesting at a rate of one-third per year on December 31, 2024.
  • [F3]The stock options vested at the rate of 25% per year commencing on April 1, 2017.
  • [F4]The stock options vested at the rate of one-third per year commencing on September 23, 2020.
  • [F5]The stock options vested at the rate of one-third per year commencing on September 27, 2022.
Signature
/s/ Robert Anderson by P.O.A. for Luis de la Aguilera|2026-01-28

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4